RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Johnson & Johnson - Stock

Johnson & Johnson Net Income 2024

Johnson & Johnson Net Income

25.83 B USD

Ticker

JNJ

ISIN

US4781601046

WKN

853260

In 2024, Johnson & Johnson's profit amounted to 25.83 B USD, a -26.52% increase from the 35.15 B USD profit recorded in the previous year.

The Johnson & Johnson Net Income history

YEARNET INCOME (undefined USD)
2029e29.91
2028e29.79
2027e28.3
2026e27.86
2025e26.53
2024e25.83
202335.15
202217.94
202120.88
202014.71
201915.12
201815.3
20171.3
201616.54
201515.41
201416.32
201313.83
201210.85
20119.67
201013.33
200912.27
200812.95
200710.58
200611.05
200510.06
20048.18

Johnson & Johnson Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Johnson & Johnson, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Johnson & Johnson from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Johnson & Johnson’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Johnson & Johnson. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Johnson & Johnson’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Johnson & Johnson’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Johnson & Johnson’s growth potential.

Johnson & Johnson Revenue, Profit, and EBIT History

DateJohnson & Johnson RevenueJohnson & Johnson EBITJohnson & Johnson Net Income
2029e103.52 B USD0 USD29.91 B USD
2028e101.32 B USD33.8 B USD29.79 B USD
2027e97.36 B USD31.96 B USD28.3 B USD
2026e95.15 B USD31.28 B USD27.86 B USD
2025e91.88 B USD30.02 B USD26.53 B USD
2024e89.32 B USD29.04 B USD25.83 B USD
202385.16 B USD24.25 B USD35.15 B USD
202279.99 B USD23.29 B USD17.94 B USD
202178.74 B USD20.63 B USD20.88 B USD
202082.58 B USD20.52 B USD14.71 B USD
201982.06 B USD18.6 B USD15.12 B USD
201881.58 B USD20.22 B USD15.3 B USD
201776.45 B USD19.39 B USD1.3 B USD
201671.89 B USD20.93 B USD16.54 B USD
201570.07 B USD20.47 B USD15.41 B USD
201474.33 B USD21.21 B USD16.32 B USD
201371.31 B USD17.07 B USD13.83 B USD
201267.22 B USD17.14 B USD10.85 B USD
201165.03 B USD13.41 B USD9.67 B USD
201061.59 B USD17.18 B USD13.33 B USD
200961.9 B USD17.19 B USD12.27 B USD
200863.75 B USD17.18 B USD12.95 B USD
200761.1 B USD14.68 B USD10.58 B USD
200653.32 B USD14.38 B USD11.05 B USD
200550.51 B USD13.05 B USD10.06 B USD
200447.35 B USD12.34 B USD8.18 B USD

Johnson & Johnson stock margins

The Johnson & Johnson margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Johnson & Johnson. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Johnson & Johnson.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Johnson & Johnson's sales revenue. A higher gross margin percentage indicates that the Johnson & Johnson retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Johnson & Johnson's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Johnson & Johnson's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Johnson & Johnson's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Johnson & Johnson. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Johnson & Johnson's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Johnson & Johnson Margin History

Johnson & Johnson Gross marginJohnson & Johnson Profit marginJohnson & Johnson EBIT marginJohnson & Johnson Profit margin
2029e69.18 %0 %28.89 %
2028e69.18 %33.36 %29.41 %
2027e69.18 %32.83 %29.07 %
2026e69.18 %32.87 %29.28 %
2025e69.18 %32.68 %28.88 %
2024e69.18 %32.51 %28.92 %
202369.18 %28.48 %41.28 %
202269.25 %29.11 %22.43 %
202170.28 %26.2 %26.52 %
202065.7 %24.84 %17.82 %
201966.54 %22.67 %18.42 %
201866.92 %24.78 %18.75 %
201766.84 %25.36 %1.7 %
201669.9 %29.11 %23.01 %
201569.38 %29.21 %21.99 %
201469.4 %28.54 %21.96 %
201369.63 %23.94 %19.4 %
201267.78 %25.5 %16.14 %
201168.69 %20.62 %14.87 %
201069.49 %27.89 %21.65 %
200970.2 %27.77 %19.82 %
200870.96 %26.96 %20.31 %
200770.95 %24.03 %17.31 %
200671.76 %26.97 %20.73 %
200572.27 %25.82 %19.92 %
200471.54 %26.06 %17.28 %

Johnson & Johnson Aktienanalyse

What does Johnson & Johnson do?

Johnson & Johnson is an American company that was founded in 1886 by the brothers Robert, James, and Edward Johnson. The company is headquartered in New Brunswick, New Jersey, USA and is now an internationally operating company with more than 130,000 employees worldwide. The history of Johnson & Johnson began with the production of medical bandages. In 1887, the first self-adhesive wound plaster was invented and patented. In the following years, the product range was significantly expanded and now includes a wide range of health products. This includes pharmaceuticals, medical devices, hygiene products, personal care products, and baby products. The business model of Johnson & Johnson is to improve the lives of people worldwide. The company places great importance on innovation, quality, and sustainability. With its long-standing experience and expertise in the healthcare industry, Johnson & Johnson is able to understand the needs of customers and offer products tailored to their specific needs. Johnson & Johnson is now active in three main business areas: Consumer Health, Medical Devices and Diagnostics, and Pharmaceuticals. Within these business areas, there are a variety of brands and products that are among the most well-known in the world. The Consumer Health division of Johnson & Johnson is focused on the production of health and personal care products for consumers. Some well-known brands in this area include Listerine, Johnson's Baby, Neutrogena, and Nicorette. The company offers a wide range of products, from cold and allergy medications to skincare products and toothpastes. Medical Devices and Diagnostics is another major business area of Johnson & Johnson. The company is a leading provider of medical devices and diagnostic products worldwide. Products in this area include surgical systems, implantable devices, diagnostic tests, and imaging devices. Well-known brands in this area include Ethicon, Depuy Synthes, and Cordis. Pharmaceuticals is the third major business area of Johnson & Johnson. The company develops and produces innovative pharmaceuticals for the treatment of diseases such as cancer, diabetes, heart disease, and neurological disorders. Some well-known brands in this area include Remicade, Invega, and Zytiga. Johnson & Johnson is also known for its commitment to sustainability and corporate social responsibility. The company is committed to having a positive impact on the environment and the communities in which it operates. For example, Johnson & Johnson aims to reduce its CO2 emissions by 60% by 2030. Overall, Johnson & Johnson is a leading healthcare company focused on providing innovative and high-quality products that improve the lives of people worldwide. With a wide range of brands and products in various business areas, the company is well positioned to continue to be successful in the future. Johnson & Johnson ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Johnson & Johnson's Profit Margins

The profit margins of Johnson & Johnson represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Johnson & Johnson's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Johnson & Johnson's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Johnson & Johnson's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Johnson & Johnson’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Johnson & Johnson Stock

How much profit has Johnson & Johnson made this year?

Johnson & Johnson has made 25.83 B USD this year.

How has the profit developed compared to last year?

The profit has increased by -26.52% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Johnson & Johnson publish its earnings?

Johnson & Johnson publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Johnson & Johnson?

The profits of Johnson & Johnson are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Johnson & Johnson?

You can learn more about the earnings of Johnson & Johnson by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Johnson & Johnson pay?

Over the past 12 months, Johnson & Johnson paid a dividend of 4.7 USD . This corresponds to a dividend yield of about 3.22 %. For the coming 12 months, Johnson & Johnson is expected to pay a dividend of 5.1 USD.

What is the dividend yield of Johnson & Johnson?

The current dividend yield of Johnson & Johnson is 3.22 %.

When does Johnson & Johnson pay dividends?

Johnson & Johnson pays a quarterly dividend. This is distributed in the months of September, December, March, June.

How secure is the dividend of Johnson & Johnson?

Johnson & Johnson paid dividends every year for the past 63 years.

What is the dividend of Johnson & Johnson?

For the upcoming 12 months, dividends amounting to 5.1 USD are expected. This corresponds to a dividend yield of 3.49 %.

In which sector is Johnson & Johnson located?

Johnson & Johnson is assigned to the 'Health' sector.

Wann musste ich die Aktien von Johnson & Johnson kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Johnson & Johnson from 6/4/2024 amounting to 1.24 USD, you needed to have the stock in your portfolio before the ex-date on 5/20/2024.

When did Johnson & Johnson pay the last dividend?

The last dividend was paid out on 6/4/2024.

What was the dividend of Johnson & Johnson in the year 2023?

In the year 2023, Johnson & Johnson distributed 4.45 USD as dividends.

In which currency does Johnson & Johnson pay out the dividend?

The dividends of Johnson & Johnson are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Johnson & Johnson stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank

Andere Kennzahlen von Johnson & Johnson

Our stock analysis for Johnson & Johnson Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Johnson & Johnson Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.